SZ
Suzuken Co., Ltd.
SZUKF · OTC
$30.30 +0.00% (+$0.00)
Market Cap ¥316.6B
P/E Ratio 8.01x
Div. Yield 2.15%
ROE 9.63%
Bulios Fair Price
$22.33
26.3% downside
Current Price
$30.3
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SZUKF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap PEG 0.49x
P/S 0.13x
P/B 0.77x
Growth
58 /100
Stable Rev. growth 2.44%
Book val. growth 0.84%
EPS growth 40.71%
Profitability
7 /100
Weak Net margin 1.56%
Op. margin 1.39%
FCF margin 0.00%
Quality
45 /100
Average ROE 9.63%
ROA 3.33%
Asset turnover 2.13x
Debt
93 /100
Low Current ratio 1.22x
Int. coverage 968.95x
Net debt/EBITDA -1.80x
Stability
77 /100
Stable Rev. volatility 1.65%
EPS volatility 12.60%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SZUKF
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Shigeru Asano
Employees
12,717
Headquarters
Nagoya
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
05 NOV
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date